Fund shareholders of KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
ISIN GB00BRXB0C07 · United States
- Fund shareholders
- 209
- Of which ETFs
- 44 165 other funds
- Value held
- ≈ 1B $ 1B $ · 9.8M SEK
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| iShares MSCI USA Small-Cap Quality Factor ETF iShares Trust | 84 | 4.1K $ | 0.05 % | as of May 31, 2026 ↗ |
| Founders 100 ETF Founder Funds Trust | 83 | 5.3K $ | 0.11 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 63 | 4K $ | 0.05 % | as of Jun 30, 2026 ↗ |
| SIMT Tax-Managed Small/Mid Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 54 | 3.5K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 52 | 3.3K $ | 0.09 % | as of Jun 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 36 | 2.7K $ | 0.03 % | as of Jul 31, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 33 | 2.5K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 23 | 1.1K $ | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 12 | 767.4 $ | 0.01 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| SMART Mid Cap ETF Tidal Trust I | 7.56 % | as of Jun 30, 2026 ↗ |
| CapForce IBD 50 ETF Capital Force ETF Trust | 4.24 % | as of Jul 31, 2026 ↗ |
| abrdn Focused U.S. Small Cap Active ETF abrdn Funds | 3.18 % | as of Jul 31, 2026 ↗ |
| 1290 Essex Small Cap Growth Fund 1290 Funds | 2.61 % | as of Jul 31, 2026 ↗ |
| abrdn U.S. Small Cap Equity Fund abrdn Funds | 2.57 % | as of Jul 31, 2026 ↗ |
| CapForce IBD Breakout Opportunities ETF Capital Force ETF Trust | 2.36 % | as of Jul 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.97 % | as of Jul 31, 2026 ↗ |
| Buffalo Early Stage Growth Fund Buffalo Funds | 1.74 % | as of Jun 30, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.42 % | as of May 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 1.41 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 208 | +82 | 15,666,074 | +35.0 % |
| 2026Q2 | 126 | +11 | 11,602,482 | +44.1 % |
| 2026Q1 | 115 | +22 | 8,048,916 | +29.7 % |
| 2025Q4 | 93 | -41 | 6,205,763 | -10.1 % |
| 2025Q3 | 134 | -51 | 6,905,515 | -34.3 % |
| 2025Q2 | 185 | +3 | 10,513,431 | -0.9 % |
| 2025Q1 | 182 | -14 | 10,604,687 | -4.4 % |
| 2024Q4 | 196 | +81 | 11,096,130 | +120.1 % |
| 2024Q3 | 115 | 5,042,286 |
Cite this page
Titelia. "Fund shareholders of KINIKSA PHARMACEUTICALS INTERNATIONAL PLC". https://titelia.com/en/stocks/kiniksa-pharmaceuticals-international-plc-GB00BRXB0C07